Back to Results
First PageMeta Content
Investment / Fundamental analysis / Financial ratios / Valuation / Financial accounting / Earnings before interest / taxes / depreciation and amortization / Net profit / EV/EBITDA / Income / Finance / Generally Accepted Accounting Principles / Business


1QFY13 Result Update Institutional Equities Sun Pharmaceutical Industries 13 August 2012
Add to Reading List

Document Date: 2012-08-17 03:32:28

Open Document

File Size: 446,49 KB

Share Result on Facebook

City

Mumbai / /

Company

Sun Pharmaceutical Industries / Johnson & Johnson / Taro / Doxil / SUN / Bloomberg / 1M 6M 1 Yr Sun Pharma / Downgrade / Nirmal Bang Equities Pvt. Ltd. / 3M / /

Country

United States / India / /

Currency

USD / Rs / /

/

Event

M&A / /

/

IndustryTerm

alternate contract manufacturer / /

Person

Loss / /

/

Position

CEO / Hemindra Hazari Head of Research hemindra.hazari@nirmalbang.com / /

Product

Prandin / /

Technology

API / CMP / /

SocialTag